Introduction
Spontaneous bleeding in adults is not an uncommon clinical presentation. In a majority of patients, an underlying cause for the bleeding is found. These include disorders of primary and secondary hemostasis such as inhibitors to coagulation factors, chronic liver disease and disseminated intravascular coagulation. There still is a minority of patients, however, in whom, despite extensive evaluation, no clear cause for the bleeding is identified.
We were faced with such a situation when a 63-year-old white man presented with a 1 week history of spontaneous bruising of his right flank and left thigh. Initial investigations did not reveal any platelet abnormalities. The prothrombin time and activated partial thromboplastin time were prolonged but there were no consistent coagulation factor abnormalities. We therefore went on to investigate the fibrinolytic system, which revealed antiplasmin deficiency [1] . The following presentation details the series of investigations undertaken to determine the cause of the patient's bleeding disorder.
Case report
Our patient, a 63-year-old white man, presented to our hematology clinic with complaints of spontaneous bruising for 1 week. He had no history of trauma, previous bleeding episodes or a family history of bleeding disorders. Physical examination revealed bruises in his right flank and a 0.15 Â 0.2 m 2 left inner-thigh hematoma. Initial laboratory studies, presented in Table 1 , demonstrated a hemoglobin level of 98 g/l and a normal platelet count. The prothrombin time and activated partial thromboplastin time were prolonged at 17.1 and 38.9 s, respectively. A mixing study failed to fully correct, but did not give the typical pattern of a coagulation factor inhibitor. A lupus inhibitor screen was negative. Coagulation factor assays did not reveal any conclusive abnormalities. The patient's antiplasmin activity, however, was at 35% of normal. A type-1 defect was identified when a Laurell immunoassay showed that his antigen was proportionately decreased at 30%.
The patient was treated with low doses of e-aminocaproic acid for his antiplasmin deficiency. This resulted in resolution of the hematomas, normalization of his hemoglobin and no further bleeding episodes. To better characterize his type-1 antiplasmin deficiency we proceeded to sequence his antiplasmin gene.
Fifteen months from original presentation, the patient was admitted to our institution with anasarca and newonset nephrotic range proteinuria. Treatment with e-aminocaproic acid was continued but his hospitalization was complicated by a sepsis syndrome, multi-organ failure and death. At the request of his family no autopsy was performed.
Materials and methods
Platelet aggregation studies and coagulation factor assays were performed by standard techniques. Activatable plasminogen was measured by a chromogenic assay utilizing streptokinase as the activator (Technoclone, Vienna, Austria). Tissue plasminogen activator levels and plasmin-antiplasmin levels were measured by sandwich enzyme-linked immunosorbent assay technique (Technoclone). A chromogenic assay was used to determine antiplasmin function (Quest Labs, San Juan, California, USA).
Antiplasmin was measured by electroimmunodiffusion (Laurell technique) using polyclonal rabbit anti-human antiplasmin (Nordic Labs, Tillburg, The Netherlands). Pooled normal plasma obtained from 20 normal donors was used as the 100% standard. The coding sequence of the patient's antiplasmin gene was determined using genomic DNA extracted from whole blood using a QIAmp mini kit (Qiagen, Valencia, California, USA). Polymerase chain reaction primers were designed from the published genomic sequence [2] , using the Primer-3 program [3] . Primers for exons 1-10, inclusive of the promoter region and splice junctions, are detailed in Table 2 .
Exons 1-10, splice junctions and the promoter region of the antiplasmin gene were amplified by the polymerization chain reaction method in a minicycler using a touchdown program [4] . In this program denaturation occurs at 928C for 1 min and amplification proceeds for 1 min at 728C during each cycle. During initial amplification, annealing temperatures decrease from 70 to 558C over 14 cycles. Subsequent amplification proceeds after the products have been annealed at 558C for 25 cycles. Exon 10 was amplified in four overlapping sections due to its large size (1143 base pairs). Polymerase chain reaction products were purified using the Promega Wizard DNA purification system. Nucleotide sequencing was performed by the Dye-deoxy method (ABI 377; PE Biosystems, Foster City, California, USA).
Results
Hemostatic factors did not show any consistent defects and are detailed in Table 1 .
Antiplasmin levels in our patient were consistently decreased at 30-35% of normal. Both the antigen and activity of antiplasmin were proportionately decreased, thus identifying a type-1 defect. The sequence of his antiplasmin gene showed no candidate mutations that would explain his deficiency. All splice junctions and 70 base pairs upstream of exon 1 were normal. Three heterozygous polymorphisms were found. The first polymorphism, C to T, in exon 2 causes substitution of alanine by valine at position À26 in the signal peptide [5] . The next polymorphism, C to T, in exon 3 causes substitution of arginine by tryptophan at position 6 and, finally, G to A in exon 10 causes substitution of arginine by lysine at position 407. These three polymorphisms have been previously found in blood donors [6] . Their presence in our patient ruled out major gene deletions.
Discussion
In this report we describe an older patient who presented with a new spontaneous bleeding disorder. Investigations demonstrated an isolated type-1 deficiency of antiplasmin that was successfully treated with e-aminocaproic acid.
Antiplasmin, a serine protease inhibitor [7] , is the most important physiological inhibitor of plasmin [8] . It is synthesized primarily in the liver [9] with a plasma concentration of 0.7 mg/l. The human gene for antiplasmin was sequenced in 1988 [2] and has been mapped to human chromosome 17 [10] . The gene contains 10 exons and nine introns spanning approximately 16 kbases DNA [2] .
The amino acid sequence of antiplasmin has been deduced and the full-length mature protein is 464 amino acids long [5] and contains three functional regions. The 464-amino-acid form (Met form) is converted by the antiplasmin-cleaving enzyme [11] to the 452-amino-acid form (Asn form) [5] . The Asn form is present in plasma as 60% of the total antiplasmin [5] and is physiologically more active than the Met form [12] .
Congenital deficiencies of antiplasmin leading to bleeding are very rare and the real prevalence of these disorders is not known [13] . Congenital antiplasmin deficiency is inherited in an autosomal recessive fashion. Homozygotes in general have a severe bleeding disorder, while heterozygotes have a milder version [14] . Some patients with heterozygotic mutations in the antiplasmin gene have presented with clinically significant bleeding late in life [15] . Based on these reports, we investigated the possibility of a heterozygous mutation in the antiplasmin gene causing a bleeding disorder in our patient. On sequencing, his antiplasmin gene was found to have three heterozygous polymorphisms that have been identified in blood donors [6] . The polymorphisms are widely distributed in the gene sequence, effectively ruling out a major gene deletion. Small deletions were ruled out by the sequence results.
This raises important questions about the patient's antiplasmin deficiency. Having ruled out a major gene deletion, how might the lack of antiplasmin be explained? Either epigenetic factors involved in the regulation of gene transcription or translational factors could be responsible for his deficiency. Although nonneutralizing antibodies [16] to antiplasmin causing increased clearance have not been reported in the literature, this could explain the patient's type-1 deficiency.
Another important question is why do people with heterozygous deficiencies of antiplasmin present with bleeding late in life? Age-related vascular or connective tissue defects may unmask a dormant-inherited bleeding disorder, although none was identified in our patient. Unfortunately his demise due to the development of nephrotic syndrome and sepsis leaves us without answers to these questions. There is no documented case linking nephrotic syndrome with the use of e-aminocaproic acid.
In conclusion, deficiency of antiplasmin must be considered in the work-up of any patient who presents with a spontaneous bleeding disorder [1] , even in a older patient, since the response to antifibrinolytics can be dramatic.
